Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer ...

Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer In experimental models, human CAR-T cells manufactu ...

In a sweeping new map of the adult Drosophila melanogaster brain, researchers at the University of Oxford found that mature ...

A collaborative effort led by Professor Wanli Liu 's team at Tsinghua University has uncovered a sophisticated mechanism by which keratinocytes, the predominant cell type in the skin's epidermis, ...

The skin is far more than a simple physical barrier. These two researches address a fundamental question in immunology: How does a localized skin ...

Barclays 28th Annual Global Healthcare Conference March 12, 2026 11:30 AM EDTCompany ParticipantsDinesh Patel - ...

Thank you for standing by for Li Auto's Fourth Quarter and Full Year 2025 Earnings Conference Call. [Operator Instructions] Today's conference call is being recorded. I will now turn the call over to ...

CD4+ T cells, long regarded as supporting actors in cancer immunity, are emerging as central regulators of tumor control and ...

For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor cell ...

T cell activation—the process by which these key immune defenders recognize threats and mobilize against them—depends on exquisitely timed molecular signals. Now researchers have captured one of the ...

The approach relies on a specially engineered scaffold that links three naturally occurring cytokines known to promote immune memory.

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...